Clinical trials recruiting for Carcinoma, Hepatocellular
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Extended Dosing Interval - A | 1 |
| Extended Dosing Interval - B | 1 |
| Extended Dosing Interval - C | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 1 |
| Illinois | 1 |
| Indiana | 1 |
| Massachusetts | 1 |
| Michigan | 1 |
| Minnesota | 1 |
| New York | 1 |
| North Carolina | 1 |
| Ohio | 1 |
| Pennsylvania | 1 |
| Texas | 1 |
| Virginia | 1 |
Top cities
Self-screener
Recruiting trials
- A Value-Driven Study on Reducing Immune Checkpoint Inhibitor Dosing Frequency in Advanced Cancers
- Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH)
- National Liver Cancer Screening Trial
Related conditions
Trials recruiting for Carcinoma, Hepatocellular often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Carcinoma, Hepatocellular trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.